W. Günzburg

发表

Rapid and Sensitive Detection of Enhanced Green Fluorescent Protein Expression in Paraffin Sections by Confocal Laser Scanning Microscopy

Dieter Klein, Ingrid Walter, M. Fleischmann, 2000, The Histochemical Journal.

A 470 bp WAP-promoter fragment confers lactation independent, progesterone regulated mammary-specific gene expression in transgenic mice

Brian Salmons, W. Günzburg, K. Lipnik, 2005, Transgenic Research.

3 Retroviral Vectors

Brian Salmons, W. Günzburg, 2001 .

Green fluorescent protein retroviral vector : generation of high-titer producer cells and virus supernatant.

W. Uckert, W. Günzburg, L. Pedersen, 2000, Methods in molecular medicine.

Rafts, anchors and viruses--a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors.

Brian Salmons, W. Günzburg, C. Metzner, 2008, Virology.

Retroviral gene therapy--where now?

W. Günzburg, 2003, Trends in molecular medicine.

Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study

H. Bergmeister, M. Löhr, U. Losert, 1999, Journal of Molecular Medicine.

Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.

J. Lengler, Brian Salmons, W. Günzburg, 2006, Biochemical pharmacology.

The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction

D. Klein, Mathias Müller, Brian Salmons, 2002, Cancer Gene Therapy.

GMP Production of an Encapsulated Cell Therapy Product: Issues and Considerations

Brian Salmons, W. Günzburg, O. Hauser, 2007 .

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

Brian Salmons, W. Günzburg, M. Renner, 2011, Journal of Neuro-Oncology.

Development of an efficient and safe integration system for the production of transgenic farm animals

G. Brem, Brian Salmons, W. Günzburg, 1996 .

Mutations in the catalytic core or the C-terminus of murine leukemia virus (MLV) integrase disrupt virion infectivity and exert diverse effects on reverse transcription.

D. Klein, Brian Salmons, W. Günzburg, 2007, Virology.

Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter.

W. Günzburg, S. Nikol, E. Krausz, 1999, Atherosclerosis.

Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial

M. Löhr, T. Wagner, H. Nizze, 2003 .

Molecularly Characterised Xenograft Tumour Mouse Models: Valuable Tools for Evaluation of New Therapeutic Strategies for Secondary Liver Cancers

K. Zatloukal, W. Günzburg, H. Petznek, 2009, Journal of biomedicine & biotechnology.

Inducible expression of p21WAF-1/CIP-1/SDI-1 from a promoter conversion retroviral vector

D. Klein, Brian Salmons, W. Günzburg, 1997, Journal of Molecular Medicine.

Novel treatments and therapies in development for pancreatic cancer

M. Löhr, Brian Salmons, W. Günzburg, 2002, Expert opinion on investigational drugs.

Bacteriophage‐encoded toxins: the λ‐holin protein causes caspase‐independent non‐apoptotic cell death of eukaryotic cells

J. Lengler, U. Bläsi, Brian Salmons, 2007, Cellular microbiology.

Effects of Viral Strain, Transgene Position, and Target Cell Type on Replication Kinetics, Genomic Stability, and Transgene Expression of Replication-Competent Murine Leukemia Virus-Based Vectors

Brian Salmons, W. Günzburg, M. Renner, 2007, Journal of Virology.

Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.

Brian Salmons, W. Günzburg, M. Renner, 2002, Biochemical and biophysical research communications.

Tumorigenic Conversion of in vivo Differentiation Competent Mammary Cells by Introduction and Expression of ras or mil(raf) but not myc

R. Ullrich, Brian Salmons, W. Günzburg, 1989 .

Mouse mammary tumor virus infects human cells.

Brian Salmons, W. Günzburg, F. Rouault, 2005, Cancer research.

Encapsulated cells producing retroviral vectors for in vivo gene transfer

G. Esposito, V. Coppola, S. Indraccolo, 2002, The journal of gene medicine.

New generations of retroviral vector for safe, efficient and targeted gene therapy

Ingrid Walter, Brian Salmons, W. Günzburg, 2006 .

Novel clinical strategies for the treatment of pancreatic carcinoma.

Brian Salmons, W. Günzburg, 2001, Trends in molecular medicine.

Quantification and characterization of autotransduction in retroviral vector producer cells.

Brian Salmons, W. Günzburg, C. Hohenadl, 2008, Human gene therapy.

Association of glycosylphosphatidylinositol‐anchored protein with retroviral particles

Brian Salmons, W. Günzburg, C. Metzner, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein.

J. Lengler, Brian Salmons, W. Günzburg, 2005, Analytical biochemistry.

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine

P. Karle, W. Uckert, Brian Salmons, 2000, Cancer Gene Therapy.

The Diversity of Uses for Cellulose Sulphate Encapsulation

J. Abastado, J. Sinden, Brian Salmons, 2013 .

Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century

J. Ringel, M. Löhr, Brian Salmons, 2002, Cancer Chemotherapy and Pharmacology.

JMM — Past and Present

Brian Salmons, W. Günzburg, M. Renner, 2002, Journal of Molecular Medicine.

Promoter Complex in the Central Part of the Mouse Mammary Tumor Virus Long Terminal Repeat

Brian Salmons, W. Günzburg, S. Rungaldier, 2007, Journal of Virology.

Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat

H. Wagner, T. Miethke, Brian Salmons, 1993, Nature.

Intra-Arterial Instillation of Microencapsulated, Ifosfamide-Activating Cells in the Pig Pancreas for Chemotherapeutic Targeting

H. Bergmeister, M. Löhr, U. Losert, 2003, Pancreatology.

Human Endogenous Retroviral Long Terminal Repeat Sequences as Cell Type-Specific Promoters in Retroviral Vectors

D. Mager, Brian Salmons, W. Günzburg, 2009, Journal of Virology.

Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus.

D. Klein, Brian Salmons, W. Günzburg, 2001 .

Viruses and human breast cancer.

W. Günzburg, J. Lawson, N. Whitaker, 2006, Future microbiology.

A novel, mouse mammary tumor virus encoded protein with Rev-like properties.

Brian Salmons, W. Günzburg, F. Rouault, 2005, Virology.

Xenotransplantation: is the risk of viral infection as great as we thought?

Brian Salmons, W. Günzburg, W H Günzburg, 2000, Molecular medicine today.

Possibilities and limitations of molecular diagnostic methods in clinical microbiology: feline immunodeficiency virus as an example.

C. Musil, D. Klein, W. Günzburg, 2000 .

Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes

A. Lukas, Brian Salmons, W. Günzburg, 2007, Journal of Virology.

The cytotoxic activity of the bacteriophage λ‐holin protein reduces tumour growth rates in mammary cancer cell xenograft models

U. Bläsi, M. Ausserlechner, Brian Salmons, 2006, The journal of gene medicine.

Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer

Brian Salmons, W. Günzburg, M. Renner, 2012, PloS one.

Tissue- and Tumor-Specific Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors

Brian Salmons, W. Günzburg, M. Renner, 2006, Journal of Virology.

Replication-Competent Retroviral Vectors Murine Leukemia Virus-Based Tissue-and Tumor-Specific Targeting of

Brian Salmons, W. Günzburg, M. Renner, 2006 .

Multiple Modifications Allow High-Titer Production of Retroviral Vectors Carrying Heterologous Regulatory Elements

D. Klein, Brian Salmons, W. Günzburg, 2004, Journal of Virology.

In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer.

Brian Salmons, W. Günzburg, S. Nikol, 2001, Journal of microencapsulation.

Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches

Brian Salmons, W. Günzburg, C. Hohenadl, 2008, The journal of gene medicine.

retroviral and lentiviral vectors Effects of CD2 locus control region sequences on gene expression by

G. Basso, L. Chieco‐Bianchi, D. Klein, 2013 .

Magnetic field-controlled gene expression in encapsulated cells

O. Mykhaylyk, W. Günzburg, C. Hohenadl, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.

Brian Salmons, W. Günzburg, K. Lipnik, 2006, Virology.

Abundant authentic MMTV-Env production from a recombinant provirus lacking the major LTR promoter.

Brian Salmons, W. Günzburg, S. Rungaldier, 2005, Virology.

Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.

M. Schittmayer, Brian Salmons, W. Günzburg, 2005, Virology.

Rapid spread of mouse mammary tumor virus in cultured human breast cells

Brian Salmons, W. Günzburg, P. Kulich, 2007, Retrovirology.

Recent developments linking retroviruses to human breast cancer: infectious agent, enemy within or both?

Brian Salmons, W. Günzburg, J. Lawson, 2014, The Journal of general virology.

Identification of the Rem-responsive element of mouse mammary tumor virus

Brian Salmons, W. Günzburg, M. Müllner, 2008, Nucleic acids research.

Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.

Brian Salmons, W. Günzburg, M. Renner, 2004, Virology.

WPRE-mediated enhancement of gene expression is promoter and cell line specific.

Reinhard Klein, Brian Salmons, W. Günzburg, 2006, Gene.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression.

Brian Salmons, W. Günzburg, M. Egerbacher, 2005, Gene.

Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.

Brian Salmons, W. Günzburg, 2005, Acta biochimica Polonica.

MouseMammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional in Vitro and in Vivo

Brian Salmons, W. Günzburg, C. Hohenadl, 2014 .

Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional In Vitro and In Vivo

Brian Salmons, W. Günzburg, C. Hohenadl, 2008, Journal of biomedicine & biotechnology.

Conditional expression of human TNF‐α: A system for inducible cytotoxicity

W. Uckert, Brian Salmons, W. Günzburg, 1994 .

Intratumoral conversion of flucytosine to 5-fluorouracil using a novel MLV-based replication-competent retroviral vector carrying the cytosine deaminase gene (Toca 511) in an immune-competent model of glioblastoma.

W. Günzburg, H. Gruber, J. Robbins, 2010 .

Comment on Patel et al; "Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses" Nanomedicine, 2015. 11(5): p. 1097-107.

Brian Salmons, W. Günzburg, C. Metzner, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors

D. Klein, Brian Salmons, W. Günzburg, 2009, BMC Molecular Biology.

Encapsulation of Insulin Producing Cells for Diabetes Treatment Using Alginate and Cellulose Sulphate as Bioencapsulation Polymers

Brian Salmons, W. Günzburg, J. Dangerfield, 2014 .

A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.

Brian Salmons, W. Günzburg, M. Renner, 2002, Journal of molecular medicine.

Combination suicide gene therapy.

W. Uckert, Brian Salmons, W. Günzburg, 2004, Methods in molecular medicine.

Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours

W. Łopuszyński, Brian Salmons, W. Günzburg, 2014, PloS one.

Characterization of a Human Cell Clone Expressing Cytochrome P450 for Safe Use in Human Somatic Cell Therapy

P. Karle, Brian Salmons, W. Günzburg, 1999, Annals of the New York Academy of Sciences.

Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial.

M. Löhr, Brian Salmons, W. Günzburg, 2002, Journal of gastroenterology.

Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide

P. Karle, Brian Salmons, W. Günzburg, 2001, Cancer Gene Therapy.

Microencapsulation of genetically engineered cells for cancer therapy.

Robert Saller, Brian Salmons, W. Günzburg, 2002, Methods in enzymology.

Magnetic field-controlled gene expression in encapsulated cells

O. Mykhaylyk, W. Günzburg, C. Hohenadl, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Rapid spread of mouse mammary tumor virus in cultured human breast cells

Brian Salmons, W. Günzburg, P. Kulich, 2007 .

Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells

D. Noël, W. Günzburg, W. Günzburg, 1998, Gene Therapy.

Xenotransplantation: a summary of the International Business Communications' Fourth International Congress.

W. Günzburg, 2000 .

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model

W. Günzburg, H. Petznek, J. Hlavaty, 2013, Cancer Gene Therapy.